Decrease in New Cancer Diagnoses Seen in 2020
There was a decrease in new cancer diagnoses, relative to expected numbers, between March 2020 and May 2020, according to a report.
There was a decrease in new cancer diagnoses, relative to expected numbers, between March 2020 and May 2020, according to a report.
Language barriers may hinder access to cancer care before patients even encounter a physician, a new study suggests.
The incidence of early-onset cancers (diagnosed before age 50) has been increasing in recent years, according to a population-based study.
The prevalence of TERT promoter mutations among patients with cancer differs by race and sex, a large study suggests.
Patients receiving Gavreto for RET-mutant MTC should be informed of the withdrawal and given other care options.
Lenalidomide does not improve upon treatment with cediranib in patients with radioactive iodine-refractory differentiated thyroid cancer, a study suggests.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Many thyroid cancer survivors said they lacked understanding of their treatment before receiving it.
The highest risk of thyroid cancer was seen in patients with both high genetic risk and an unfavorable lifestyle.
Cabozantinib prolongs progression-free survival in patients with previously treated radioiodine-refractory differentiated thyroid cancer, a phase 3 trial suggests.